Introduction
Since mouse keratinocytes are tolerogenic antigen presenting cells for T cell activation, the expression of second signal molecules such as B7-1 was targeted to epidermal keratinocytes (KC) in vivo in transgenic mice. The expression vector used to create transgenic mice consisted of a keratin 14 promoter fused 5' to the full length open reading frame of the cDNA encoding mouse B7-1 (between 10 and 30 copies of the transgene per genome). Expression of B7-1 cell surface protein was assessed by in situ immunostaining of cryostat sections of tail skin with CTLA-41Ig fusion protein, revealing high levels of cell surface expression of B7 by all epidermal KC of transgenic mice, and a lack of such expression in nontransgenic animals. The skin of such transgenic mice (derived from three different founder mice) was grossly and histologically normal, with normal numbers of Langerhans cells and dendritic epidermal T cells. Immunologic challenge of transgenic mice with epicutaneous haptens such as fluorescein isothiocyanate revealed enhanced and persistent delayed-type hypersensitivity responses, with an altered kinetics of resolution when compared with nontransgenic controls. These data indicate that in normal, nontransgenic mice, tolerogenic antigen presentation by KC plays an important physiologic role in damping T cell-mediated inflammation in the skin by competing with professional APC for TCR occupancy in antigen specific T-lymphocytes that migrate into the epidermis. This also implies that altered regulation of B7-1 gene expression by epidermal cells may account for skin "hyperresponsiveness" encountered in some chronic dermatologic disorders. (J. Clin. Invest. 1994 .94:892-898.) Key words: B7-1 antigen * costimulation * keratinocytes * transgenic miceperipheral tolerance Previous in vitro studies of antigen presentation by class II MHC-bearing keratinocytes (KC)' indicated that these cells fail to activate hapten specific T-helper cells (1) . Instead, antigen presentation by KC is tolerogenic, resulting in T cell clonal anergy (2, 3) . Similarly, in an in vivo model of antigen presentation, naive mice that are first exposed to hapten modified, class II MHC-bearing KC are hyporesponsive to subsequent sensitization by epicutaneous application of hapten, suggesting that, in vivo, antigen presentation by KC is also tolerogenic, presumably inducing clonal anergy in potentially hapten reactive Thelper cells (4) .
These observations may be explained by the current two signal model for T-lymphocyte triggering. This model describes T cell receptor occupancy by antigen-presenting cell (APG) derived class H MHC-peptide complex as the first signal for T cell activation (5); the second costimulatory signal for T cell activation has been demonstrated to be APC derived and is neither antigen specific nor MHC restricted. A large family of APC-derived costimulatory molecules has been described (6) (7) (8) (9) (10) (11) (12) . The B7 antigens (B7-1, B7-2, B7-3) are a group of molecules that effectively deliver this second signal, prevent the induction of clonal anergy and induce IL-2 production (10, 11, [13] [14] [15] . The T cell-derived costimulatory signal receptors are CD28 and CTLA-4 (10, 11, 16, 17, 17a,b with Scal, which digests a single site in pGEM3Z (2.7 kb) to create two smaller fragments (1.8, 0.9 kb). The insert DNA was separated from the two fragments by 10-40% sucrose density gradient centrifugation as described (25) , dialyzed extensively in H2O, quantitated, and resuspended in 1 x injection buffer at a concentration of 10 micrograms/ml. The DNA was then microinjected into (DBA/2J x C57BLJ6)F1 fertilized eggs which were then implanted in pseudopregnant females using standard techniques (26) .
Southern blot. Genomic DNA was extracted from tail skin, electrophoresed on 2.5% agarose gel, transferred to nitrocellulose and probed for the expression of the transgene with 32P-labeled linearized K14-mB7-C,, using standard methodology (27) .
In vitro costimulation assay. Purified T-lymphocytes were prepared from spleen cells (nontransgenic Fl mice) as previously described, using a nylon wool column followed by antibody and complement (28) . 10 were fixed for 5 min at 40C in acetone, and then washed. The specimens were then stained with uncoupled 10 Ag/mL CTLA4/Ig or control Ig.
Staining was detected using fluorescein coupled F(ab)2' fragments of goat anti-human Ig. The specimens were examined using a Jena Lumar epifluorescence microscope (Zeiss, Federal Republic of Germany); photomicrographs were also obtained using the same microscope.
Contact hypersensitivity assay. Contact sensitization to FITC was assayed as previously described (30) . Ear swelling was measured using thickness gauge calipers (Swiss Precision Instruments, Carlstadt, NJ) at the time points indicated after challenge on the pinna of the ear. Treatment groups included sensitized and naive mice (n = 4 in each group), with both transgenic and nontransgenic mice being studied. Data is reported as the mean change in ear thickness, AT = [(Thickness after challenge) -(Baseline Thickness)], plus/minus the standard error of the mean.
For the in vivo blocking study of the ear swelling response in transgenic mice, groups (four animals in each group) of naive transgenic mice were challenged on the pinna of the ear with a single epicutaneous application of 20 j1 of 0.5% FITC. Before this challenge, one group of animals was treated with a single intradermal injection of CTLA-4/1g 20 .tg in a 20 kdI volume (blockade group); another group of transgenic mice received 20 itl of phosphate buffered saline (control group). A third group of mice (nontransgenics) served as a negative control for the ear swelling response in naive mice, and received a single epicutaneous application of 0.5% FITC without any prior injections. Ear swelling was then measured at the indicated time intervals.
Statistical analysis. The ear swelling data were analyzed for statistical significance using the one tailed, paired student's t test (software program Statview SE + graphics, Abacus Concepts, Berkeley, CA.) P values < 0.05 were considered significant.
Results
Transgenic mice were identified using Southern blotting of genomic DNA (BamHI digest) extracted from tail skin. As depicted in Fig. 2 To demonstrate that KC from transgenic mice expressed functional B7-1, we studied the ability of such KC to costimulate T cell proliferation (100,000/well) in response to polyclonal T cell activators such as Concanavalin A (10 ug/ml). As depicted in Fig. 5 A, cultured KC (7,500/well) from transgenic mice costimulated significant mitogen induced T cell proliferation, whereas equal numbers of KC from nontransgenic controls failed to induce any response. The costimulation provided by such transgenic KC was dependent on B7-1 expression, as CTLA-4/Ig blocked, in a dose dependent fashion (1 or 10 ug/ mL), the ability of transgenic KC (6,000/well) to support T cell (Fig. 5 B) . Fig. 6, A and B) . However, at later time points completely, resulting in histologically normal skin (Fig. 7 B) . 
